People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Applied Stemcell Inc | — | Biotechnology | Series B | $23.5M | $754.1M | 2010 |
| QuanDx, Inc. | — | Biotechnology | Seed | $4.3M | $133.2M | 2013 |
| Cb Therapeutics Inc. | — | Other Health Care | Seed | $4.0M | $99.1M | 2016 |
| Nvigen, Inc. | — | Biotechnology | Seed | $2.1M | $49.6M | 2014 |
Guoliang Yu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Guoliang Yu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Wang | 1 | 5 |
| James Zhu | 1 | 4 |
| Peng Cheng | 1 | 3 |
| Shengjiang Liu | 1 | 3 |
| Guo-Liang Yu | 1 | 2 |
| Alex Wu | 1 | 2 |
| Bing Zhu | 1 | 1 |
| Sanjeev Redkar | 1 | 1 |
| Xiangdong Jin | 1 | 1 |
| Xiaojun Lei | 1 | 1 |
| Aihua Fu | 1 | 1 |
| Ruhong Jiang | 1 | 1 |
| Grace Tian | 1 | 1 |
| Dean Tsao | 1 | 1 |
| Chunlin Liang | 1 | 1 |
| Zhenyu Xiao | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.